Effect of Ginko and Cistanche Against Fatigue Symptoms

NCT02807649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2016-06-21

No results posted yet for this study

Summary

To evaluate the efficacy of Nutrilite® ginkgo biloba cistanche tablets in relieving the symptoms of chronic fatigue syndrome(CFS), the investigators randomly recruit189 subjects with CFS, aged 35-60 yrs. The relief of fatigue and improvement of sexual function are evaluated by World Health Organization Quality Of Life Brief (WHOQoL-Bref), Sexual Life Quality Questionnaire (SLQQ), chronic fatigue syndrome, symptoms of self-assessment at the baseline and the end of intervention. Subjects also underwent a blood test measuring the concentration of biochemical indicators. Cistanche is mainly used to strengthen the renal function, nourish essence and blood in the treatment of lumbar debility, impotence, infertility and muscles weakness, constipation. etc. The study is to test the hypothesis that consecutive 60-day intake of the study tablets can relieve the symptoms of CFS; according to the change of blood biology indicators, the investigators will also evaluate the association between the change of plasma outcome measures and chronic fatigue syndrome.

Conditions

  • Mental Fatigue
  • Fatigue
  • Chronic Fatigue Syndrome

Interventions

DIETARY_SUPPLEMENT

Experimental: Nutrilite® Low dose

Two tablets consume daily with meal.

DIETARY_SUPPLEMENT

Experimental: Nutrilite® High dose

Two tablets consume daily with meal.

DIETARY_SUPPLEMENT

Placebo Comparator: Placebo

Two tablets consume daily with meal.

Sponsors & Collaborators

  • Sinphar Pharmaceutical Co., Ltd

    collaborator OTHER
  • Sprim Advanced Life Sciences

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Access Business Group

    lead INDUSTRY

Principal Investigators

  • Shuguang Li, PhD · Fudan University, Department of Nutrition and Food Hygiene

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-10-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02807649 on ClinicalTrials.gov